Qiagen has introduced the rat druggable genome siRNA set, a collection of siRNAs targeting roughly 6,000 rat genes corresponding to human genes of therapeutic potential.
According to the company, the siRNAs are provided either individually or in pools. Subsets targeting 426 GPCR genes, 738 kinase genes, or 198 phosphatase genes are also available.